Publications
231
Citations
9,818
Est. group size
~6
Recurring co-author estimate
Active years
37
Publishing since 1989
Typically publishes in teams of ~17 · 6% small-team papers (≤3 authors) · across 49 venues
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF SARACATINIB IN IDIOPATHIC PULMONARY FIBROSIS
CHEST Journal · 2025
- Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinoma
Oral Oncology · 2025
- Abstract C074: Supporting language access for persons with a cancer diagnosis
Cancer Epidemiology Biomarkers & Prevention · 2025
- <scp>PET</scp> ‐ <scp>CT</scp> Test Properties for <scp>HPV</scp> Positive Unknown Primary of the Neck: A <scp>FIND</scp> Trial Correlative Study
Head & Neck · 2025
- A Case Report of Cervical Necrotizing Fasciitis developed to Mediastinitis
International Journal of Oral and Maxillofacial Surgery · 2025
- Abstract 1498 Regulation of DNA damage response by protein myristoylation
Journal of Biological Chemistry · 2025
- PENELOPE: A randomized phase II trial of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab with or without nesuparib, in patients with newly diagnosed advanced or recurrent MMR-proficient endometrial cancer.
Journal of Clinical Oncology · 2025
- 3583 Efficacy of administering pentoxifylline, tocopherol, with or without clodronate, to irradiated head and neck cancer patients with osteoradionecrosis
Radiotherapy and Oncology · 2025
- Tnfα Induces Abnormal Pericyte-Mediated Vascular Remodeling in a Novel Model of CTD-PAH
American Journal of Respiratory and Critical Care Medicine · 2025
- 7. Rupture of Breast Implants Does Not Cause Systemic or Local Immune Changes
Plastic & Reconstructive Surgery Global Open · 2025
- Abstract 1470: Inhibition of protein myristoylation sensitizes pancreatic cancer cells to DNA damage agents
Cancer Research · 2025
- Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma
Oral Oncology · 2025
- An open-label, dose-finding, phase Ib study to assess the safety, tolerability of nesuparib (JPI-547), a dual inhibitor of PARP/TNKS, in combination with modified FOLFIRINOX (mFOLFIRINOX) and gemcitabine-nab-paclitaxel (GemAbraxane) in patients with locally advanced and metastatic pancreatic cancer.
Journal of Clinical Oncology · 2025
- The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiation
Radiotherapy and Oncology · 2025
- Papillary thyroid carcinoma in a branchial cleft cyst
Endocrinology Diabetes and Metabolism Case Reports · 2025
- Radiotherapy and Oncology×27
- Oral Oncology×11
- International Journal of Radiation Oncology*Biology*Physics×8
- Journal of Clinical Oncology×8
- Radiology Case Reports×7
- Clifford M. Chang
Medicine · University of Michigan
- David Forner
Medicine · University of Michigan
- Marisa R. Buchakjian
Medicine · University of Michigan
- Amit Agrawal
Medicine · The Ohio State University
- Gregory T. Wolf
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile